Megan Herink practices in adult family medicine. Her research interests include improving medication management in the primary care setting, chronic disease management, and transition of care from the hospital to the community. She also works with the Drug Use Research and Management program, providing evidence based reviews to guide drug policy decisions in the Oregon Medicaid program.
Herink M, Ito MK. Medication Induced Changes in lipids and Lipoproteins. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; July 2015
Meeker A, Herink M, Haxby D, Hartung D. The Safety and Efficacy of Vortioxetine for Acute Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis. Systematic Reviews. (2015) 4:21
Rackham D, Herink M, Stevens I, Cardoza N, Singh H. Evidence behind FDA Alerts for Drugs with Adverse Cardiovascular Effects: Implications for Clinical Practice. Pharmacotherapy. April 2014;34(4):358-372.
Packard K, Herink M, Lenz T. Comparison of Traditional Versus Evidence-Based Journal Club Formats. Innovations in Pharmacy. 2011;2:1-14
Packard K, Herink M, Kuhlman P. Pharmacist’s Role in an Interdisciplinary Cardiac Rehabilitation Team. J Allied Health. 2012 Fall;41(3):113-7